NEWS
Mesoblast pain drug agreement downgraded by German partner
MELBOURNE: Mesoblast and its German pharmaceutical partner Grünenthal have downgraded their collaboration agreement by about… read more
Imugene shares soar on US breast cancer trial
MELBOURNE: Cancer vaccine making biotech Imugene opened 8.6 per cent higher this morning after gaining… read more
Hawaii holiday prize promised for vaccinated staff
SYDNEY: One of Australia’s largest fertility providers is offering staff the chance to win a… read more
